Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-2,414
Closed -$591K 423
2021
Q2
$591K Buy
2,414
+232
+11% +$60.9K 0.06% 190
2021
Q1
$578K Sell
2,182
-1,259
-37% -$355K 0.07% 207
2020
Q4
$1.01M Sell
3,441
-2,227
-39% -$571K 0.12% 55
2020
Q3
$1.34M Sell
5,668
-803
-12% -$183K 0.15% 121
2020
Q2
$1.28M Buy
+6,471
New +$1.21M 0.13% 142

Other funds holding AMED

AGF Investments LLC's AMED Position: Q3 2021 in Review

AGF Investments LLC sold out of Amedisys (AMED) in Q3 2021, closing a stake of 2,414 shares — an estimated $591K sold.

AGF Investments LLC first reported a position in AMED in Q2 2020 and held it in 5 quarters. The position peaked at $1.34M in Q3 2020. 351 funds tracked by Wall St. Rank hold AMED as of Q3 2021.

  • AGF Investments LLC reported no remaining Amedisys position as of Q3 2021 after selling out during the quarter.
  • AGF Investments LLC sold 2,414 Amedisys shares in Q3 2021, an estimated $591K.
  • AGF Investments LLC first reported a position in Amedisys in Q2 2020 and held it in 5 quarters.
  • AGF Investments LLC's Amedisys position peaked at $1.34M in Q3 2020.
  • 351 funds tracked by Wall St. Rank held Amedisys as of Q3 2021.

Based on AGF Investments LLC's 13F filing for Q3 2021, filed 10 Nov 2021.